Correlation Engine 2.0
Clear Search sequence regions


  • amino acid motifs (1)
  • asthma (2)
  • balb c mice (2)
  • cell number (1)
  • cells (2)
  • control group (4)
  • eosinophils (2)
  • female (1)
  • GPI (2)
  • lung (4)
  • lymphocytes (1)
  • mice (4)
  • ovalbumin (1)
  • RECK (8)
  • rna (2)
  • Sizes of these terms reflect their relevance to your search.

    To investigate the expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) in the lung tissues of bronchial asthmatic mice and the effect of dexamethasone treatment on its expression. Thirty BALB/c mice were randomly divided into three equal groups: a control group, an asthmatic group and a dexamethasone-treated group. The asthmatic mouse models were established by intraperitoneal injection and inhalation with ovalbumin (OVA). The number of eosinophils (EOS) and lymphocytes (Lym) in bronchoalveolar lavage fluid (BALF) were counted. HE staining was used to observe airway inflammation and remodeling. The mRNA and protein expression of RECK were determined by real-time PCR and immunohistochemistry, respectively. Compared with the control group and the dexamethasone-treated group, the total cell number and EOS number in the BALF of the asthma group significantly increased. The expression of RECK mRNA in the asthmatic group was significantly lower than that in the control group and the dexamethasone-treated group. Immunohistochemistry showed that RECK was mainly expressed in the airway epithelial cells and inflammatory cells. RECK protein expression was highest in the control group and lowest in the asthmatic group. Dexamethasone can increase the expression of RECK in the lung tissues of asthmatic mice.

    Citation

    Zhenxing Li, Sheng He, Liping Wei, Lin Lin, Hanzhen Xiong, Junhong Li, Peifen Chen, Wenyan Lai. Dexamethasone increases the expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) in lung tissues of bronchial asthmatic mice]. Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology. 2016 May;32(5):604-8

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 27126937

    View Full Text